Back
Halozyme Therapeutics Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
51
HALO
Halozyme Therapeutics
Last Price:
$46.95
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.62 | Sell |
| 20-day SMA: | 48.12 | Sell |
| 50-day SMA: | 51 | Sell |
| 200-day SMA: | 50.14 | Sell |
| 8-day EMA: | 47.61 | Sell |
| 20-day EMA: | 48.45 | Sell |
| 50-day EMA: | 50.73 | Sell |
| 200-day EMA: | 50.06 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.11 | Sell |
| Relative Strength Index (14 RSI): | 40.79 | Sell |
| Chaikin Money Flow: | -4132103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.97 - 48.99) | Sell |
| Bollinger Bands (100): | (49.23 - 60.41) | Sell |
Halozyme Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 46.93 while HALO 8-day simple moving average is 47.62, which is a Sell signal.
-
The stock price of HALO is 46.93 while Halozyme Therapeutics 20-day SMA is 48.12, which makes it a Sell.
-
Halozyme Therapeutics 50-day simple moving average is 51.00 while HALO share price is 46.93, making it a Sell technically.
-
HALO stock price is 46.93 and Halozyme Therapeutics 200-day simple moving average is 50.14, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $46.93. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6B
Price in USD:
46.93
Share Volume:
4.5M
Halozyme Therapeutics 52-Week Range
52-Week High:
65.53
52-Week Low:
33.15
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 46.93 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 46.93 while HALO 8-day exponential moving average is 47.61, which is a Sell signal.
-
The stock price of HALO is 46.93 while Halozyme Therapeutics 20-day EMA is 48.45, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 50.73 while HALO share price is 46.93, making it a Sell technically.
-
HALO stock price is 46.93 and Halozyme Therapeutics 200-day simple moving average is 50.06, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.11, suggesting Halozyme Therapeutics is a Sell
-
Halozyme Therapeutics Relative Strength Index (RSI) is 40.79, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (45.97 - 48.99), which suggest Halozyme Therapeutics is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics is (49.23 - 60.41), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.